Determination of Inventor

Scope of Patent Exhaustion

Consumption Tax on Damages for Patent Infringement

Enforcement of Artificial Intelligence (AI) Related Technology Patents – Claims Using Features, etc. to Specify the Inventions －

Statute of Limitations for Claim for Damages based on Patent Infringement

「Recent trend on JPO appeal decisions and Court Decisions (Chemistry)」

World Intellectual Property Forum 2022 Bangkok

Pharmaceutical Test Data Exclusivity

IP law in Japan : the recent changes

Joint Patent Infringement by Plural Actors

Q&A Practice for Prevention and Treatment of Intellectual Property Troubles “License Fee after Extinction of Patent Right by Expiration of Duration

Joint Tort of Patent Infringement

IP STARS 2022 Recommends Members of YUASA AND HARA

Claim Construction of Use Invention and Availability of Injunction and Scope of Damages on the Basis of Patent of Use Invention – Conversion of Indirect Infringing Products under Process Invention into Direct Infringement of Product Invention and Restriction of Enforcement Derived from Patentability Relying on Use in Future

Patent Infringement regarding Sale of Products to Japanese Markets by Foreign Company

Enforcement of Artificial Intelligence (AI) Related Technology Patents

Japanese version of “Amicus Curiae”

Subjective Requirements for Indirect Infringement by Products Not Exclusively Used for Patent Infringement

Prior Use Right – Modification to Accused Product/Method and Amendment to Patent Claim

Interpretation of Article 102 of Patent Act under 2019 Amendments

「Recent trend on JPO appeal and IPHC decisions (Chemistry)」

Third Party Opinion Solicitation System Introduced by the Amended Patent Act in the Era of Artificial Intelligence (AI) and IoT

Online Participation in Oral Proceedings Will be Possible as of October 1, 2021

Affixation of Seal or Signature Is No Longer Required for Most Procedures as of June 12, 2021

Patent Registration and Maintenance Fees Raised as of April 1, 2022

「Recent trend on JPO appeal decisions and IPHC Decisions (Chemistry)」

MORIMOTO, Takayuki (Ph.D.)

Our firm and attorneys received high evaluation at “2021 edition of IAM Patent 1000”.

「Does a third party infringe a patent right by conducting clinical trials on an original drug?」

YUASA and HARA has been ranked Tier 1 for Patent Prosecution & Contentious and Trademark Prosecution by Managing Intellectual Property in 2021